Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Investing.com -- The biotechnology sector continues to offer compelling investment opportunities in 2026, with several companies poised for significant growth according to Bank of America analysts.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

Invest in stocks that have not performed well recently but boast attractive prospects. Viking Therapeutics is developing ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...

But deciding if it's a good buy takes a little more looking.